Yea Christopher

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)7%8%8%0%
Sale Success Rate3 of 104 of 103 of 102 of 100 of 10

Kalvista Pharmaceuticals, I...

Drugs » Drugs - Generic

Chief Development Officer:

Holdings: 89.98K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--